Gastroesophageal reflux symptoms not responding to proton pump inhibitor: GERD, NERD, NARD, esophageal hypersensitivity or dyspepsia?

被引:12
|
作者
Bashashati, Mohammad [1 ]
Hejazi, Reza A. [2 ]
Andrews, Christopher N. [3 ]
Storr, Martin A. [1 ,4 ]
机构
[1] Univ Calgary, Gastrointestinal Res Grp, Calgary, AB, Canada
[2] Texas Tech Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Internal Med, El Paso, TX USA
[3] Univ Calgary, Dept Med, Div Gastroenterol, Calgary, AB, Canada
[4] Univ Munich, Div Gastroenterol, Munich, Germany
来源
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2014年 / 28卷 / 06期
关键词
Gastroesophageal reflux disease; Heartburn; Proton pump inhibitor; NONCARDIAC CHEST-PAIN; MULTICHANNEL INTRALUMINAL IMPEDANCE; DILATED INTERCELLULAR SPACES; IRRITABLE-BOWEL-SYNDROME; EOSINOPHILIC ESOPHAGITIS; SPHINCTER RELAXATIONS; FUNCTIONAL HEARTBURN; VISCERAL HYPERSENSITIVITY; EROSIVE ESOPHAGITIS; HEALTHY-VOLUNTEERS;
D O I
10.1155/2014/904707
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Gastroesophageal reflux (GER) is a common gastrointestinal process that can generate symptoms of heartburn and chest pain. Proton pump inhibitors (PPIs) are the gold standard for the treatment of GER; however, a substantial group of GER patients fail to respond to PPIs. In the past, it was believed that acid reflux into the esophagus causes all, or at least the majority, of symptoms attributed to GER, with both erosive esophagitis and nonerosive outcomes. However, with modern testing techniques it has been shown that, in addition to acid reflux, the reflux of nonacid gastric and duodenal contents into the esophagus may also induce GER symptoms. It remains unknown how weakly acidic or alkaline refluxate with a pH similar to a normal diet induces GER symptoms. Esophageal hypersensitivity or functional dyspepsia with superimposed heartburn may be other mechanisms of symptom generation, often completely unrelated to GER. Detailed studies investigating the pathophysiology of esophageal hypersensitivity are not conclusive, and definitions of the various disease states may overlap and are often confusing. The authors aim to clarify the pathophysiology, definition, diagnostic techniques and medical treatment of patients with heartburn symptoms who fail PPI therapy.
引用
收藏
页码:335 / 341
页数:7
相关论文
共 50 条
  • [31] Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association
    Aanen, Marissa C.
    Weusten, Bas L. A. M.
    Numans, Mattijs E.
    de Wit, Niek J.
    Samsom, Melvin
    Smout, Andre J. P. M.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2008, 42 (05) : 441 - 447
  • [32] Most Patients With Gastroesophageal Reflux Disease Who Failed Proton Pump Inhibitor Therapy Also Have Functional Esophageal Disorders
    Abdallah, Jason
    George, Nina
    Yamasaki, Takahisa
    Ganocy, Stephen
    Fass, Ronnie
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (06) : 1073 - +
  • [33] Reduction of proton pump inhibitor (PPI) usage in patients with gastroesophageal reflux disease (GERD) after undergoing stretta procedure, an East Malaysia perspective
    Tan, Phei Oon
    Ng, Chuin Yann
    Koleth, Glenn
    Goh, Thee Ken
    Loganathan, Nerenthran
    Tan, Jun Ee
    Chettiar, Raman Muthukaruppan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 54 - 55
  • [34] Dysphagia Associated with Gastroesophageal Reflux Disease Is Improved by Proton Pump Inhibitor
    Kayoko Oda
    Ryuichi Iwakiri
    Megumi Hara
    Kazuyo Watanabe
    Akiko Danjo
    Ryo Shimoda
    Atsushi Kikkawa
    Akifumi Ootani
    Hiroyuki Sakata
    Seiji Tsunada
    Kazuma Fujimoto
    Digestive Diseases and Sciences, 2005, 50 : 1921 - 1926
  • [35] Effect of a Preoperative Proton Pump Inhibitor and Gastroesophageal Reflux Disease on Postoperative Nausea and Vomiting
    Kwon, Young Suk
    Choi, Jun Woo
    Lee, Ho Seok
    Kim, Jong Ho
    Kim, Youngmi
    Lee, Jae Jun
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (03)
  • [36] Dysphagia associated with gastroesophageal reflux disease is improved by proton pump inhibitor
    Oda, K
    Iwakiri, R
    Hara, M
    Watanabe, K
    Danjo, A
    Shimoda, R
    Kikkawa, A
    Ootani, A
    Sakata, H
    Tsunada, S
    Fujimoto, K
    DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (10) : 1921 - 1926
  • [37] Frequency scale for symptoms of gastroesophageal reflux disease predicts the need for addition of prokinetics to proton pump inhibitor therapy
    Miyamoto, Masaki
    Haruma, Ken
    Takeuchi, Keisuke
    Kuwabara, Masao
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 (05) : 746 - 751
  • [38] Gastroesophageal reflux disease in primary care: Using changes in proton pump inhibitor therapy as an indicator of partial response
    Ruigomez, Ana
    Johansson, Saga
    Wernersson, Boerje
    Fernandez Cantero, Oscar
    Garcia Rodriguez, Luis A.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2012, 47 (07) : 751 - 761
  • [39] Is empiric proton pump inhibition in patients with symptoms of extraesophageal gastroesophageal reflux justified?
    Fossmark, Reidar
    Ness-Jensen, Eivind
    Sordal, Oystein
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [40] Effect of potassium competitive acid blocker compared to proton pump inhibitor in gastroesophageal reflux disease
    Wepee, Roderick, Jr.
    Te, Marilyn
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 278 - 278